Actavis/Forest: roll up, tax down

[at Financial Times] – Buy drug company, cut operating costs, cut research spending, pay less tax, watch stock go up. It is a simple plan, and Actavis is sticking to it. The only question is how often the process can be repeated. … more

View todays social media effects on VRX

View the latest stocks trending across Twitter. Click to view dashboard

See who Valeant is hiring next, click here to view